Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis
Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients with coronavirus disease (COVID-19) remains controversial.Methods: We identified randomized controlled trials, prospective cohort studies, and retrospective studies on associations between aspirin or other...
Saved in:
Main Authors: | Wanting Su (Author), He Miao (Author), Zhaotian Guo (Author), Qianhui Chen (Author), Tao Huang (Author), Renyu Ding (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
by: Baorui Wang, et al.
Published: (2023) -
Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
by: Hemlata, et al.
Published: (2013) -
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
by: Pi L, et al.
Published: (2018) -
Associations of combined lifestyle behaviors with all-cause and cardiovascular mortality in adults: A population-based cohort study in Jiangxi Province of China
by: Tao Wang, et al.
Published: (2022) -
Association of retinopathy with risk of all-cause and specific-cause mortality in the National Health and Nutrition Examination Survey, 2005 to 2008
by: Si-Yu Gui, et al.
Published: (2023)